ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,475.09
0.27%
US Tech 100
19,275.90
0.58%
다우존스 지수
39,169.52
0.13%
Bitcoin
63,056.62
0.73%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. USOTC
  6. Immune Therapeutics Inc (PK) (IMUN)

  7. Immune Therapeutics Inc (PK) (IMUN) 뉴스

IMUN

Immune Therapeutics (PK) (IMUN)

Immune Therapeutics Inc (PK)
일자:
정렬 기준:
 검색 관련기사 보기:USOTC:IMUN
일자시간출처헤드라인심볼기업
2024/05/2103:57Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IMUNImmune Therapeutics Inc (PK)
2024/05/1519:15Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:IMUNImmune Therapeutics Inc (PK)
2024/04/0121:05Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:IMUNImmune Therapeutics Inc (PK)
2023/11/1506:22Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
2023/11/1501:43Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IMUNImmune Therapeutics Inc (PK)
2023/11/0222:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
2023/10/2422:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
2023/09/1422:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
2023/09/1406:16Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IMUNImmune Therapeutics Inc (PK)
2023/08/1819:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IMUNImmune Therapeutics Inc (PK)
2023/08/1423:03Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:IMUNImmune Therapeutics Inc (PK)
2023/04/2022:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
2023/04/1103:48Edgar (US Regulatory)Annual Report (10-k)USOTC:IMUNImmune Therapeutics Inc (PK)
2023/04/0101:03Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:IMUNImmune Therapeutics Inc (PK)
2023/03/0707:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
2023/01/1300:01Edgar (US Regulatory)Information Statements (revised) (prer14c)USOTC:IMUNImmune Therapeutics Inc (PK)
2022/12/1706:33Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:IMUNImmune Therapeutics Inc (PK)
2022/12/1606:49Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:IMUNImmune Therapeutics Inc (PK)
2022/12/1606:48Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:IMUNImmune Therapeutics Inc (PK)
2022/11/1502:27Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IMUNImmune Therapeutics Inc (PK)
2022/11/1007:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
2022/10/1221:50Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
2022/09/2803:38Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
2022/09/0103:59Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:IMUNImmune Therapeutics Inc (PK)
2022/08/2506:17Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IMUNImmune Therapeutics Inc (PK)
2022/08/0223:48Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:IMUNImmune Therapeutics Inc (PK)
2022/07/2304:45Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
2022/07/0806:28Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
2022/06/0405:58Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IMUNImmune Therapeutics Inc (PK)
2022/05/0405:22Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IMUNImmune Therapeutics Inc (PK)
 검색 관련기사 보기:USOTC:IMUN

최근 히스토리

CCOM
SILVER
SILVER
NYSE
MCD
McDonalds
NASDAQ
TSLA
Tesla
USI
USTECH100
US Tech 100
NYSE
CVX
Chevron
AMEX
XLE
Energy Select Sector SPDR
NYSE
NKE
Nike
SPI
SP500
S&P 500
COIN
BTCUSD
Bitcoin
NYSE
VZ
Verizon Communications
CCOM
US30
US 30
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLV
Health Care Select Sector
AMEX
SPY
SPDR S&P 500
COIN
ETHUSD
Ethereum
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유